
Korea United Pharm Inc., specialized in the human healthcare field, has manufactured, marketed and sold pharmaceutical products since 1987, with a broad range of OTC and prescription products including about 30 kinds of anti-cancer medicines exported to more than 42 countries worldwide. Investing more than 10% of annual turnover in R&D, the company seeks to expand its portfolio with a focus on developing incrementally modified drugs (IMDs) offering fewer side effects and improved drug compliance, supported by branch offices in the Philippines, Myanmar, Vietnam, Indonesia and Thailand that help deliver high-quality healthcare products and services promptly to customers worldwide.

暂无评论。
留下您的评分和评论